Publications by authors named "Jesus Magallon"

Claim this Profile
F
Full Validation of Pooled Antibiotic Susceptibility Testing Using CLSI Methods and Performance Criteria in UTI Pathogens.
Richard A Festa, Frank R Cockerill, Rick L Pesano, Emery Haley, Natalie Luke, Jesus Magallon

Antibiotics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards.
Richard A Festa, Frank R Cockerill, Rick L Pesano, Emery Haley, Natalie Luke, Jesus Magallon

Antibiotics (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine biomarkers individually and as a consensus model show high sensitivity and specificity for detecting UTIs.
Marzieh Akhlaghpour, Emery Haley, Laura Parnell, Natalie Luke, Mohit Mathur, Jesus Magallon

BMC Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A test combining multiplex-PCR with pooled antibiotic susceptibility testing has high correlation with expanded urine culture for detection of live bacteria in urine samples of suspected UTI patients.
Richard A Festa, Natalie Luke, Mohit Mathur, Laura Parnell, Dakun Wang, Jesus Magallon

Diagn Microbiol Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative multiplex polymerase chain reaction in copies ml-1 linearly correlates with standard urine culture in colonies ml-1 for urinary tract infection (UTI) pathogens.
Richard A Festa, Mike Opel, Mohit Mathur, Natalie Luke, Laura K S Parnell, Jesus Magallon

Lett Appl Microbiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility.
Jesus Magallon, Peter Vu, Craig Reeves, Stella Kwan, Kimberly Phan

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin in combination with zinc pyrithione prevents growth of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae isolate.
Jesus Magallon, Peter Vu, Craig Reeves, Stella Kwan, Kimberly Phan

Int J Antimicrob Agents· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Aminoglycoside 6'--acetyltransferase Type Ib (AAC(6')-Ib): Structure-Activity Relationship of Substituted Pyrrolidine Pentamine Derivatives as Inhibitors.
Kenneth Rocha, Jesus Magallon, Craig Reeves, Kimberly Phan, Peter Vu

Biomedicines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoglycoside 6'--acetyltransferase Type Ib [AAC(6')-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions.
Craig M Reeves, Jesus Magallon, Kenneth Rocha, Tung Tran, Kimberly Phan

Antibiotics (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.
Jesus Magallon, Kevin Chiem, Tung Tran, Maria S Ramirez, Veronica Jimenez

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
Kevin Chiem, Fong Hue, Jesus Magallon, Marcelo E Tolmasky

Int J Antimicrob Agents· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis